15/12/2025 14:35
Morgan Stanley raised the target price for Ali Health (00241) to HKD4.6 from HKD4.2 and maintained the "underweight" rating.
The research house said it raises FY26-28e revenue by 5.5%/6.7%/7.1%, respectively, reflecting the strong sales momentum in the online drug segment and the updated company guidance.
樂本健【年度感謝祭】維柏健及natural Factors全線2件7折► 了解詳情
上一篇新聞︰15/12/2025 16:00 {I-bank focus}Citi raises Li Ning (02331) to HKD20.6
下一篇新聞︰12/12/2025 16:08 {I-bank focus}Citi lowers China Res Power (00836) to HKD19
16/12/2025 16:08 {I-bank focus}Citi raises China Shenhua (01088) to HKD45.1
16/12/2025 14:43 {I-bank focus}Morgan lowers ZTE (00763) to HKD31.5
12/12/2025 14:40 {I-bank focus}Morgan raises COSCO Ship Hold to HKD10.3
11/12/2025 16:05 {I-bank focus}UBS lowers Giant Biogene (02367) to HKD39.5
11/12/2025 14:32 {I-bank focus}J.P. Morgan lowers Brilliance Chi to HKD4.1
